Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the AstraZeneca Pharma India Limited has approved the appointment of Praveen Akkinepally as the Business Unit Head – Oncology with effect from November 1, 2023. Praveen will be part of the senior management team of the company.

Praveen holds an MBA from The University of Michigan, Ross School of Business and a Master in Public Health from Johns Hopkins University, Bloomberg School of Public Health.

He has been recognized by Diversity MBA Magazine in their annual Top 100 Under 50 list of Executive and Emerging Leaders. Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA.